Recent News
- ‘Access to Health’ to improve stroke care in Africa
- New research in glioblastoma
- MHRA approves donanemab…
- Fast track approval in Fabry disease?
- Bepranemab Phase 2a study
- Oditrasertib in multiple sclerosis – phase 2 trial stopped
- Lundbeck enhances neuroscience pipeline
- Epilepsy drug may treat obstructive sleep apnoea
- Enhancing MRI with AI to improve diagnosis of brain disorders
- Parkinson’s disease therapy Vyalev gets FDA approval
Categories
- ACNR News (8)
- Acquired Brain Injury (13)
- Alzheimer's Disease (22)
- Amyotrophic Lateral Sclerosis (ALS) (7)
- Artificial Intelligence (6)
- Association of British Neurologists Trainees (4)
- Australia/New Zealand (1)
- Awards & Appointments (6)
- Book Reviews (2)
- Brain Mapping (2)
- Brain tumours (3)
- Case Reports (15)
- Charcot-Marie-Tooth Disease (1)
- Charity (5)
- Cognition (1)
- Comment (2)
- Course & Conference Previews (11)
- Courses & Conferences (1)
- COVID-19 Articles (3)
- Dementia (8)
- Digital Health (2)
- Epilepsy (15)
- Essay (1)
- Headache (16)
- Hereditary Spastic Paraplegia (1)
- Huntington's disease (2)
- Industry News (177)
- Journal Reviews (1)
- Major Depressive Disorder (3)
- Management Topics in Epilepsy (1)
- Movement Disorders (5)
- Multiple Sclerosis (27)
- Myasthenia Gravis (7)
- Neurodegenerative diseases (1)
- Neurodevelopmental disorders (3)
- Neuroimmunology (2)
- Neurological Literature (2)
- Neurology News (37)
- Neuropsychiatry (2)
- Neurosurgery (1)
- NHS News (2)
- Online First (14)
- Pain (4)
- Parkinson’s Disease (22)
- Rehabilitation (10)
- Rehabilitation Articles (4)
- Research (4)
- Sleep (2)
- Sleep Series (4)
- Special Feature (6)
- Sponsored Feature (7)
- Stroke (9)
- Stroke Series (3)
- Syncope (1)
- Uncategorised (43)
- Uncategorized (1)